-
Je něco špatně v tomto záznamu ?
The world apheresis association registry, 2023 update
H. Vrielink, K. Le Poole, B. Stegmayr, J. Kielstein, G. Berlin, O. Ilhan, GC. Seval, H. Prophet, A. Aandahl, D. Deeren, I. Bojanic, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, S. Blahutova, R. Hrdlickova, J. Audzijoniene, A....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- dárci tkání MeSH
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- novorozenec MeSH
- plazmaferéza MeSH
- předškolní dítě MeSH
- registrace MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- separace krevních složek * metody MeSH
- výměna plazmy škodlivé účinky MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of procedures and adverse events (AEs). MATERIAL AND METHODS: The WAA-registry is used for registration of apheresis procedures and is free of charge. The responsible person for a center can apply at the site www.waa-registry.org RESULTS: Data includes reported AEs from 2012 and various procedures and diagnoses during the years 2018-2022; the latter in total from 27 centers registered a total of 9500 patients (41% women) that began therapeutic apheresis (TA) during the period. A total of 58,355 apheresis procedures were performed. The mean age was 50 years (range 0-94). The most common apheresis procedure was stem cell collection for which multiple myeloma was the most frequent diagnosis (51%). Donor cell collection was done in 14% and plasma exchange (PEX) in 28% of patients; In relation to all performed procedures PEX, using a centrifuge (35%) and LDL-apheresis (20%) were the most common. The main indication for PEX was TTP (17%). Peripheral veins were used in 56% as the vascular access. The preferred anticoagulant was ACD. AEs occurred in 2.7% of all procedures and were mostly mild (1%) and moderate 1.5% (needed supportive medication) and, only rarely, severe (0.15%). CONCLUSION: The data showed a wide range of indications and variability in apheresis procedures with low AE frequency.
4 Internal Hematological Klinik Fakultni Nemocnice Hradec Králové Czech Republic
Apheresis Center University Hospital Orebro Sweden
Apheresis Department Institute of Hematology and Blood Transfusion Prague Czech Republic
Blood Centre University Hospital Ostrava Ostrava Czech Republic
Dep of Immunology and Transfusion Medicine Akershus University Hospital Lorenskog Norway
Department Haematology University Hospital Ankara Turkey
Department of Clinical Microbiology Division of Clinical Immunology Umeå University Umeå Sweden
Department of Nephrology University Hospital Uppsala Sweden
Nephrocare Rostock GmbH Rostock Germany
Public Health and Clinical Medicine Umeå University Umeå Sweden
South African National Blood Service Johannesburg South Africa
St Anna Kinderspital University Hospital Vienna Austria
Therapeutic apheresis unit Vilnius university hospital Santariskiu clinics Vilnius Lithuania
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000424
- 003
- CZ-PrNML
- 005
- 20240213093155.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.transci.2023.103831 $2 doi
- 035 __
- $a (PubMed)37827962
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vrielink, Hans $u Unit of Transfusion medicine of Sanquin Blood Supply, Sanquin Blood Supply Foundation in Amsterdam, the Netherlands
- 245 14
- $a The world apheresis association registry, 2023 update / $c H. Vrielink, K. Le Poole, B. Stegmayr, J. Kielstein, G. Berlin, O. Ilhan, GC. Seval, H. Prophet, A. Aandahl, D. Deeren, I. Bojanic, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, S. Blahutova, R. Hrdlickova, J. Audzijoniene, A. Griskevicius, T. Glatt, V. Strineholm, M. Ott, T. Nilsson, E. Newman, K. Derfler, V. Witt, F. Toss
- 520 9_
- $a The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of procedures and adverse events (AEs). MATERIAL AND METHODS: The WAA-registry is used for registration of apheresis procedures and is free of charge. The responsible person for a center can apply at the site www.waa-registry.org RESULTS: Data includes reported AEs from 2012 and various procedures and diagnoses during the years 2018-2022; the latter in total from 27 centers registered a total of 9500 patients (41% women) that began therapeutic apheresis (TA) during the period. A total of 58,355 apheresis procedures were performed. The mean age was 50 years (range 0-94). The most common apheresis procedure was stem cell collection for which multiple myeloma was the most frequent diagnosis (51%). Donor cell collection was done in 14% and plasma exchange (PEX) in 28% of patients; In relation to all performed procedures PEX, using a centrifuge (35%) and LDL-apheresis (20%) were the most common. The main indication for PEX was TTP (17%). Peripheral veins were used in 56% as the vascular access. The preferred anticoagulant was ACD. AEs occurred in 2.7% of all procedures and were mostly mild (1%) and moderate 1.5% (needed supportive medication) and, only rarely, severe (0.15%). CONCLUSION: The data showed a wide range of indications and variability in apheresis procedures with low AE frequency.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a separace krevních složek $x metody $7 D001781
- 650 _2
- $a výměna plazmy $x škodlivé účinky $7 D010951
- 650 _2
- $a plazmaferéza $7 D010956
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a dárci tkání $7 D014019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Le Poole, Kaatje $u Unit of Transfusion medicine of Sanquin Blood Supply, Sanquin Blood Supply Foundation in Amsterdam, the Netherlands
- 700 1_
- $a Stegmayr, Bernd $u Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. Electronic address: bernd.stegmayr@umu.se
- 700 1_
- $a Kielstein, Jan $u Academic Teaching Hospital Braunschweig, Medical Clinic V - Nephrology, Rheumatology, Blood Purification, Germany
- 700 1_
- $a Berlin, Gösta $u Department of Clinical Immunology and Transfusion Medicine, and Department of Biochemical and Clinical Sciences, Linköping University, Linköping, Sweden
- 700 1_
- $a Ilhan, Osman $u Department Haematology, University Hospital, Ankara, Turkey
- 700 1_
- $a Seval, Guldane Cengiz $u Department Haematology, University Hospital, Ankara, Turkey
- 700 1_
- $a Prophet, Heinrich $u Nephrocare Rostock GmbH, Rostock, Germany
- 700 1_
- $a Aandahl, Astrid $u Dep of Immunology and Transfusion Medicine, Akershus University Hospital, Lorenskog, Norway
- 700 1_
- $a Deeren, Dries $u AZ Delta, Roeselare, Belgium
- 700 1_
- $a Bojanic, Ines $u Clinical Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Croatia
- 700 1_
- $a Blaha, Milan $u IV. Internal Hematological Klinik, Fakultni Nemocnice, Hradec Králové, Czech Republic
- 700 1_
- $a Lanska, Miriam $u IV. Internal Hematological Klinik, Fakultni Nemocnice, Hradec Králové, Czech Republic
- 700 1_
- $a Gasova, Zdenka $u Apheresis Department, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Bhuiyan-Ludvikova, Zdenka $u Apheresis Department, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Blahutova, Sarka $u Blood Centre, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Hrdlickova, Radomira $u Blood Centre, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Audzijoniene, Judita $u Therapeutic apheresis unit, Vilnius university hospital Santariskiu clinics, Vilnius, Lithuania
- 700 1_
- $a Griskevicius, Antanas $u Therapeutic apheresis unit, Vilnius university hospital Santariskiu clinics, Vilnius, Lithuania
- 700 1_
- $a Glatt, Tanya $u South African National Blood Service, Johannesburg, South Africa
- 700 1_
- $a Strineholm, Virginia $u Apheresis Center, University Hospital, Orebro, Sweden
- 700 1_
- $a Ott, Michael $u Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
- 700 1_
- $a Nilsson, Thomas $u Department of Nephrology, University Hospital, Uppsala, Sweden
- 700 1_
- $a Newman, Elizabeth $u Bone Marrow Transplant & Apheresis, Apheresis & Cell Therapies Unit, Concord Repatriation General Hospital, Concord, NSW, Australia
- 700 1_
- $a Derfler, Kurt $u The Institute for the Diagnosis and Therapy of Atherosclerosis and Fat Metabolism Disorders, Athos, Vienna, Austria
- 700 1_
- $a Witt, Volker $u St. Anna Kinderspital, University Hospital, Vienna, Austria
- 700 1_
- $a Toss, Fredrik $u Department of Clinical Microbiology, Division of Clinical Immunology, Umeå University, Umeå, Sweden
- 773 0_
- $w MED00008583 $t Transfusion and apheresis science $x 1473-0502 $g Roč. 62, č. 6 (2023), s. 103831
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37827962 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093152 $b ABA008
- 999 __
- $a ok $b bmc $g 2049220 $s 1210118
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 62 $c 6 $d 103831 $e 20231007 $i 1473-0502 $m Transfusion and apheresis science $n Transfus Apher Sci $x MED00008583
- LZP __
- $a Pubmed-20240109
